Delivery Order SPE2DB22D3016-SPE2DB24FAET8
Award Date 12/4/23
Potential Completion Date 12/5/23
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,010.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,043,264 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FT93T, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,693.49 delivery order contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used for the emergency treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2024. This award is part of a larger Indefinite Delivery...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB23FEEQ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,417.78 firm-fixed-price delivery order is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,960.76, is for the delivery of Naloxone HCL 4 mg Nasal Spray 2s, a critical medical product used to treat opioid overdoses. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award, valued at $10,007.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdose. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,321.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,244,594 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the emergency treatment of opioid overdose. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,039.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,830,894 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price, with a completion date of May 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $2,782.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,182,545 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This is a firm fixed-price delivery order with a completion date of June 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...